25 XP   0   0   10

Esperion Therapeutics Inc
Buy, Hold or Sell?

Let's analyse Esperion together

PenkeI guess you are interested in Esperion Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Esperion Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Esperion Therapeutics Inc

I send you an email if I find something interesting about Esperion Therapeutics Inc.

Quick analysis of Esperion (30 sec.)










What can you expect buying and holding a share of Esperion? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€-2.31
Expected worth in 1 year
€-2.97
How sure are you?
17.4%

+ What do you gain per year?

Total Gains per Share
€-0.67
Return On Investment
-39.7%

For what price can you sell your share?

Current Price per Share
€1.68
Expected price per share
€1.282 - €3.948
How sure are you?
50%

1. Valuation of Esperion (5 min.)




Live pricePrice per Share (EOD)

€1.68

Intrinsic Value Per Share

€3.13 - €4.20

Total Value Per Share

€0.82 - €1.89

2. Growth of Esperion (5 min.)




Is Esperion growing?

Current yearPrevious yearGrowGrow %
How rich?-$454.9m-$289.6m-$102m-26.0%

How much money is Esperion making?

Current yearPrevious yearGrowGrow %
Making money-$52.3m-$58.4m$6.1m11.7%
Net Profit Margin-185.9%-309.6%--

How much money comes from the company's main activities?

3. Financial Health of Esperion (5 min.)




What can you expect buying and holding a share of Esperion? (5 min.)

Welcome investor! Esperion's management wants to use your money to grow the business. In return you get a share of Esperion.

What can you expect buying and holding a share of Esperion?

First you should know what it really means to hold a share of Esperion. And how you can make/lose money.

Speculation

The Price per Share of Esperion is €1.676. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Esperion.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Esperion, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €-2.31. Based on the TTM, the Book Value Change Per Share is €-0.17 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.16 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Esperion.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.30-18.2%-0.24-14.5%-0.32-18.8%-0.25-14.9%-0.25-15.1%
Usd Book Value Change Per Share-0.24-14.5%-0.18-10.6%-0.17-10.2%-0.14-8.6%-0.11-6.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.24-14.5%-0.18-10.6%-0.17-10.2%-0.14-8.6%-0.11-6.4%
Usd Price Per Share3.03-1.66-5.96-19.97-22.41-
Price to Earnings Ratio-2.49--1.63--4.74--9.12--12.46-
Price-to-Total Gains Ratio-12.45--16.78--160.76--71.86--74.48-
Price to Book Ratio-1.23--0.77--3.80-64.99-64.69-
Price-to-Total Gains Ratio-12.45--16.78--160.76--71.86--74.48-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.7867836
Number of shares559
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.18-0.14
Usd Total Gains Per Share-0.18-0.14
Gains per Quarter (559 shares)-99.09-80.67
Gains per Year (559 shares)-396.37-322.69
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-396-4060-323-333
20-793-8020-645-656
30-1189-11980-968-979
40-1585-15940-1291-1302
50-1982-19900-1613-1625
60-2378-23860-1936-1948
70-2775-27820-2259-2271
80-3171-31780-2581-2594
90-3567-35740-2904-2917
100-3964-39700-3227-3240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%2.018.00.010.0%2.021.00.08.7%2.021.00.08.7%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%3.017.00.015.0%4.019.00.017.4%4.019.00.017.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.023.00.0%0.00.023.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%3.017.00.015.0%4.019.00.017.4%4.019.00.017.4%

Fundamentals of Esperion

About Esperion Therapeutics Inc

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol (LDL-C). Its marketed products include NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets that are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia or atherosclerotic cardiovascular disease who require additional lowering of LDL-C. The company's products also include NILEMDO, an ATP Citrate Lyase (ACL) inhibitor that lowers LDL-C and cardiovascular risk by reducing cholesterol biosynthesis and up-regulating the LDL receptors; and NUSTENDI, a bempedoic acid and ezetimibe tablet to treat elevated LDL-C. The company has license and collaboration agreements with Daiichi Sankyo Co. Ltd to; Otsuka Pharmaceutical Co., Ltd; and Daiichi Sankyo Europe GmbH. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

Fundamental data was last updated by Penke on 2024-04-05 06:16:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Esperion Therapeutics Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Esperion earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Esperion to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -174.7% means that €-1.75 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Esperion Therapeutics Inc:

  • The MRQ is -174.7%. The company is making a huge loss. -2
  • The TTM is -185.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-174.7%TTM-185.9%+11.2%
TTM-185.9%YOY-309.6%+123.7%
TTM-185.9%5Y-1,519.0%+1,333.1%
5Y-1,519.0%10Y-1,320.9%-198.1%
1.1.2. Return on Assets

Shows how efficient Esperion is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Esperion to the Drug Manufacturers - Specialty & Generic industry mean.
  • -27.4% Return on Assets means that Esperion generated €-0.27 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Esperion Therapeutics Inc:

  • The MRQ is -27.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -23.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-27.4%TTM-23.0%-4.4%
TTM-23.0%YOY-19.6%-3.4%
TTM-23.0%5Y-18.6%-4.4%
5Y-18.6%10Y-20.2%+1.6%
1.1.3. Return on Equity

Shows how efficient Esperion is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Esperion to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Esperion generated €0.00 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Esperion Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-60.5%+60.5%
5Y-60.5%10Y-58.7%-1.8%

1.2. Operating Efficiency of Esperion Therapeutics Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Esperion is operating .

  • Measures how much profit Esperion makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Esperion to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Esperion Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-56.2%+56.2%
TTM-56.2%YOY-237.9%+181.7%
TTM-56.2%5Y-1,396.3%+1,340.1%
5Y-1,396.3%10Y-1,214.1%-182.1%
1.2.2. Operating Ratio

Measures how efficient Esperion is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 2.67 means that the operating costs are €2.67 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Esperion Therapeutics Inc:

  • The MRQ is 2.669. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.763. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.669TTM2.763-0.094
TTM2.763YOY3.736-0.973
TTM2.7635Y22.176-19.414
5Y22.17610Y19.284+2.893

1.3. Liquidity of Esperion Therapeutics Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Esperion is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.29 means the company has €1.29 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Esperion Therapeutics Inc:

  • The MRQ is 1.287. The company is just able to pay all its short-term debts.
  • The TTM is 1.916. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.287TTM1.916-0.629
TTM1.916YOY3.149-1.234
TTM1.9165Y3.164-1.248
5Y3.16410Y3.255-0.092
1.3.2. Quick Ratio

Measures if Esperion is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Esperion to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.31 means the company can pay off €0.31 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Esperion Therapeutics Inc:

  • The MRQ is 0.310. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.391. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.310TTM0.391-0.081
TTM0.391YOY0.962-0.571
TTM0.3915Y0.489-0.098
5Y0.48910Y0.822-0.333

1.4. Solvency of Esperion Therapeutics Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Esperion assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Esperion to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 3.21 means that Esperion assets are financed with 321.1% credit (debt) and the remaining percentage (100% - 321.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Esperion Therapeutics Inc:

  • The MRQ is 3.211. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.740. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ3.211TTM2.740+0.471
TTM2.740YOY1.983+0.757
TTM2.7405Y1.690+1.049
5Y1.69010Y1.507+0.183
1.4.2. Debt to Equity Ratio

Measures if Esperion is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Esperion to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has €0.00 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Esperion Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y2.204-2.204
5Y2.20410Y1.975+0.230

2. Market Valuation of Esperion Therapeutics Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Esperion generates.

  • Above 15 is considered overpriced but always compare Esperion to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -2.49 means the investor is paying €-2.49 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Esperion Therapeutics Inc:

  • The EOD is -1.467. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.486. Based on the earnings, the company is expensive. -2
  • The TTM is -1.630. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.467MRQ-2.486+1.019
MRQ-2.486TTM-1.630-0.856
TTM-1.630YOY-4.744+3.113
TTM-1.6305Y-9.120+7.490
5Y-9.12010Y-12.459+3.339
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Esperion Therapeutics Inc:

  • The EOD is -2.231. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -3.780. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.386. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.231MRQ-3.780+1.549
MRQ-3.780TTM-2.386-1.394
TTM-2.386YOY-6.309+3.922
TTM-2.3865Y-5.644+3.257
5Y-5.64410Y-4.908-0.736
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Esperion is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of -1.23 means the investor is paying €-1.23 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Esperion Therapeutics Inc:

  • The EOD is -0.727. Based on the equity, the company is expensive. -2
  • The MRQ is -1.231. Based on the equity, the company is expensive. -2
  • The TTM is -0.767. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.727MRQ-1.231+0.505
MRQ-1.231TTM-0.767-0.464
TTM-0.767YOY-3.801+3.033
TTM-0.7675Y64.987-65.754
5Y64.98710Y64.691+0.296
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Esperion Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.228-0.166-27%-0.161-30%-0.135-41%-0.100-56%
Book Value Per Share---2.306-1.985-14%-1.468-36%-0.892-61%-0.690-70%
Current Ratio--1.2871.916-33%3.149-59%3.164-59%3.255-60%
Debt To Asset Ratio--3.2112.740+17%1.983+62%1.690+90%1.507+113%
Debt To Equity Ratio----0%-0%2.204-100%1.975-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.286-0.228-20%-0.296+4%-0.234-18%-0.238-17%
Free Cash Flow Per Share---0.188-0.172-9%-0.222+18%-0.213+13%-0.213+13%
Free Cash Flow To Equity Per Share---0.165-0.169+3%-0.180+9%-0.053-68%-0.053-68%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--4.196--------
Intrinsic Value_10Y_min--3.129--------
Intrinsic Value_1Y_max---0.770--------
Intrinsic Value_1Y_min---0.757--------
Intrinsic Value_3Y_max---1.406--------
Intrinsic Value_3Y_min---1.360--------
Intrinsic Value_5Y_max---0.948--------
Intrinsic Value_5Y_min---0.958--------
Market Cap310148814.592-69%525550497.280287502954.696+83%1034261172.288-49%3466426525.118-85%3889423671.400-86%
Net Profit Margin---1.747-1.859+6%-3.096+77%-15.190+769%-13.209+656%
Operating Margin----0.5620%-2.3790%-13.9630%-12.1410%
Operating Ratio--2.6692.763-3%3.736-29%22.176-88%19.284-86%
Pb Ratio-0.727+41%-1.231-0.767-38%-3.801+209%64.987-102%64.691-102%
Pe Ratio-1.467+41%-2.486-1.630-34%-4.744+91%-9.120+267%-12.459+401%
Price Per Share1.676-69%2.8401.554+83%5.589-49%18.732-85%21.018-86%
Price To Free Cash Flow Ratio-2.231+41%-3.780-2.386-37%-6.309+67%-5.644+49%-4.908+30%
Price To Total Gains Ratio-7.349+41%-12.454-16.783+35%-160.757+1191%-71.856+477%-74.482+498%
Quick Ratio--0.3100.391-21%0.962-68%0.489-37%0.822-62%
Return On Assets---0.274-0.230-16%-0.196-28%-0.186-32%-0.202-26%
Return On Equity----0%-0%-0.6050%-0.5870%
Total Gains Per Share---0.228-0.166-27%-0.161-30%-0.135-41%-0.100-56%
Usd Book Value---454994818.989-391660454.988-14%-289654521.377-36%-175886966.596-61%-136128636.335-70%
Usd Book Value Change Per Share---0.243-0.177-27%-0.171-30%-0.144-41%-0.107-56%
Usd Book Value Per Share---2.459-2.116-14%-1.565-36%-0.950-61%-0.736-70%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.304-0.243-20%-0.316+4%-0.250-18%-0.254-17%
Usd Free Cash Flow---37056066.701-33871810.969-9%-43706828.672+18%-33633510.540-9%-29246530.905-21%
Usd Free Cash Flow Per Share---0.200-0.183-9%-0.236+18%-0.227+13%-0.227+13%
Usd Free Cash Flow To Equity Per Share---0.176-0.181+3%-0.192+9%-0.057-68%-0.057-68%
Usd Market Cap330649651.237-69%560289385.150306506900.001+83%1102625835.776-49%3695557318.429-85%4146514576.080-86%
Usd Price Per Share1.787-69%3.0281.656+83%5.958-49%19.970-85%22.407-86%
Usd Profit---56344101.419-52312094.162-7%-58414855.147+4%-47636635.746-15%-48191869.354-14%
Usd Revenue--32250058.05029083552.350+11%18868783.964+71%32308408.1550%28094267.961+15%
Usd Total Gains Per Share---0.243-0.177-27%-0.171-30%-0.144-41%-0.107-56%
 EOD+2 -6MRQTTM+12 -18YOY+13 -175Y+8 -2310Y+9 -22

3.2. Fundamental Score

Let's check the fundamental score of Esperion Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.467
Price to Book Ratio (EOD)Between0-1-0.727
Net Profit Margin (MRQ)Greater than0-1.747
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.310
Current Ratio (MRQ)Greater than11.287
Debt to Asset Ratio (MRQ)Less than13.211
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.274
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Esperion Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.525
Total0/1 (0.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets205,796
Total Liabilities660,790
Total Stockholder Equity-454,994
 As reported
Total Liabilities 660,790
Total Stockholder Equity+ -454,994
Total Assets = 205,796

Assets

Total Assets205,796
Total Current Assets201,065
Long-term Assets4,731
Total Current Assets
Cash And Cash Equivalents 82,248
Net Receivables 48,494
Inventory 65,623
Other Current Assets 4,507
Total Current Assets  (as reported)201,065
Total Current Assets  (calculated)200,872
+/- 193
Long-term Assets
Property Plant Equipment 4,675
Long-term Assets  (as reported)4,731
Long-term Assets  (calculated)4,675
+/- 56

Liabilities & Shareholders' Equity

Total Current Liabilities156,224
Long-term Liabilities504,566
Total Stockholder Equity-454,994
Total Current Liabilities
Accounts payable 31,718
Total Current Liabilities  (as reported)156,224
Total Current Liabilities  (calculated)31,718
+/- 124,506
Long-term Liabilities
Long term Debt 261,596
Capital Lease Obligations Min Short Term Debt4,573
Long-term Liabilities Other 239,950
Long-term Liabilities  (as reported)504,566
Long-term Liabilities  (calculated)506,119
+/- 1,553
Total Stockholder Equity
Total Stockholder Equity (as reported)-454,994
Total Stockholder Equity (calculated)0
+/- 454,994
Other
Capital Stock118
Common Stock Shares Outstanding 178,923
Net Debt 179,348
Net Invested Capital -193,398
Net Working Capital 44,841
Property Plant and Equipment Gross 6,687



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-30
> Total Assets 
210,881
174,030
143,451
236,482
308,814
255,270
214,447
179,642
330,352
250,969
353,258
278,606
280,461
225,256
381,590
342,853
303,980
312,827
247,939
251,819
234,626
221,305
205,796
205,796221,305234,626251,819247,939312,827303,980342,853381,590225,256280,461278,606353,258250,969330,352179,642214,447255,270308,814236,482143,451174,030210,881
   > Total Current Assets 
188,883
168,210
142,632
235,221
307,121
253,460
211,714
172,629
321,371
242,803
345,896
272,575
275,174
170,668
328,972
290,819
252,478
261,785
246,683
250,605
232,125
218,227
201,065
201,065218,227232,125250,605246,683261,785252,478290,819328,972170,668275,174272,575345,896242,803321,371172,629211,714253,460307,121235,221142,632168,210188,883
       Cash And Cash Equivalents 
24,380
26,755
36,973
174,836
274,344
211,978
166,130
149,386
298,489
215,748
304,962
217,939
219,186
103,672
208,892
150,364
122,940
159,399
124,775
144,911
138,470
114,833
82,248
82,248114,833138,470144,911124,775159,399122,940150,364208,892103,672219,186217,939304,962215,748298,489149,386166,130211,978274,344174,83636,97326,75524,380
       Short-term Investments 
155,793
132,463
99,050
53,692
26,882
31,883
34,651
7,931
2,247
0
0
0
0
0
50,441
68,138
62,905
29,942
42,086
17,427
0
0
0
00017,42742,08629,94262,90568,13850,441000002,2477,93134,65131,88326,88253,69299,050132,463155,793
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
22,255
21,854
21,710
22,934
25,116
27,844
31,489
33,729
36,415
40,799
42,623
48,494
48,49442,62340,79936,41533,72931,48927,84425,11622,93421,71021,85422,25500000000000
       Other Current Assets 
0
0
0
185
198
260
928
928
0
0
0
0
0
0
0
0
0
0
9,866
5,584
4,317
6,287
4,507
4,5076,2874,3175,5849,8660000000000928928260198185000
   > Long-term Assets 
0
0
0
1,261
1,693
1,810
2,733
7,013
8,981
8,166
7,362
6,031
5,287
54,588
52,618
52,034
51,502
51,042
1,256
1,214
2,501
3,078
4,731
4,7313,0782,5011,2141,25651,04251,50252,03452,61854,5885,2876,0317,3628,1668,9817,0132,7331,8101,6931,261000
       Property Plant Equipment 
311
583
520
1,205
1,637
1,754
2,677
6,957
7,687
8,110
7,306
5,975
5,231
4,532
2,562
1,978
1,446
986
1,200
1,158
2,445
3,022
4,675
4,6753,0222,4451,1581,2009861,4461,9782,5624,5325,2315,9757,3068,1107,6876,9572,6771,7541,6371,205520583311
       Long Term Investments 
21,631
5,181
243
0
0
0
0
0
0
0
0
0
0
0
50,441
0
62,905
0
42,086
0
0
0
0
000042,086062,905050,441000000000002435,18121,631
       Intangible Assets 
56
56
56
56
56
56
56
56
0
0
56
0
0
0
0
0
0
0
0
0
0
0
0
00000000000056005656565656565656
       Other Assets 
0
0
0
0
0
0
0
0
1,294
56
0
0
0
50,000
50,000
50,000
50,000
50,000
0
0
0
0
0
0000050,00050,00050,00050,00050,000000561,29400000000
> Total Liabilities 
34,964
42,285
64,333
61,472
179,480
186,758
194,497
229,888
244,863
242,009
449,392
548,000
584,771
587,961
578,534
591,893
595,678
606,927
571,717
581,482
606,604
631,309
660,790
660,790631,309606,604581,482571,717606,927595,678591,893578,534587,961584,771548,000449,392242,009244,863229,888194,497186,758179,48061,47264,33342,28534,964
   > Total Current Liabilities 
34,964
42,285
64,333
60,025
54,312
57,518
66,080
73,453
83,881
75,947
94,069
97,893
82,644
78,485
73,352
79,085
82,275
82,345
92,308
95,486
107,173
137,708
156,224
156,224137,708107,17395,48692,30882,34582,27579,08573,35278,48582,64497,89394,06975,94783,88173,45366,08057,51854,31260,02564,33342,28534,964
       Short-term Debt 
152
0
0
184
0
0
5,236
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000005,2360018400152
       Short Long Term Debt 
152
0
0
184
0
0
5,236
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000005,2360018400152
       Accounts payable 
22,482
18,630
44,893
33,270
28,404
23,735
28,856
15,114
29,690
17,584
51,975
30,342
29,353
20,745
17,559
26,829
12,832
18,580
23,040
17,065
24,558
26,214
31,718
31,71826,21424,55817,06523,04018,58012,83226,82917,55920,74529,35330,34251,97517,58429,69015,11428,85623,73528,40433,27044,89318,63022,482
       Other Current Liabilities 
0
0
0
3,926
3,599
2,618
2,152
1,170
1,134
1,662
1,662
20,793
3,930
3,068
21,875
20,369
22,951
24,570
25,494
0
38,418
50,825
0
050,82538,418025,49424,57022,95120,36921,8753,0683,93020,7931,6621,6621,1341,1702,1522,6183,5993,926000
   > Long-term Liabilities 
0
0
0
1,447
125,168
129,240
128,417
156,435
160,982
166,062
355,323
450,107
502,127
509,476
505,182
512,808
513,403
524,582
479,409
485,996
499,431
493,601
504,566
504,566493,601499,431485,996479,409524,582513,403512,808505,182509,476502,127450,107355,323166,062160,982156,435128,417129,240125,1681,447000
       Other Liabilities 
0
0
0
655
124,409
128,420
0
0
0
1,710
1,290
1,290
2,347
2,135
634
422
211
0
0
0
0
0
0
0000002114226342,1352,3471,2901,2901,710000128,420124,409655000
> Total Stockholder Equity
175,917
131,745
79,118
175,010
129,334
68,512
19,950
-50,246
85,489
8,960
-96,134
-269,394
-304,310
-362,705
-196,944
-249,040
-1,229,432
-294,100
-1,340,036
-1,401,755
-371,978
-410,004
-454,994
-454,994-410,004-371,978-1,401,755-1,340,036-294,100-1,229,432-249,040-196,944-362,705-304,310-269,394-96,1348,96085,489-50,24619,95068,512129,334175,01079,118131,745175,917
   Common Stock
27
27
27
27
27
27
27
28
28
28
26
26
26
27
61
61
65
72
75
0
101
112
0
0112101075726561612726262628282827272727272727
   Retained Earnings Total Equity00000000000000000000000
   Accumulated Other Comprehensive Income 00000000000000000000000
   Capital Surplus 00000000000000000000000
   Treasury Stock00000000000000000000000
   Other Stockholders Equity 
-776
-560
-319
-111
-16
11
23
9
0
0
0
0
0
0
-31
-263
-297
-93
-2
0
0
0
0
0000-2-93-297-263-3100000092311-16-111-319-560-776



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue116,334
Cost of Revenue-43,267
Gross Profit73,06773,067
 
Operating Income (+$)
Gross Profit73,067
Operating Expense-271,897
Operating Income-155,563-198,830
 
Operating Expense (+$)
Research Development86,107
Selling General Administrative142,523
Selling And Marketing Expenses-
Operating Expense271,897228,630
 
Net Interest Income (+$)
Interest Income-
Interest Expense-58,976
Other Finance Cost-0
Net Interest Income-58,976
 
Pretax Income (+$)
Operating Income-155,563
Net Interest Income-58,976
Other Non-Operating Income Expenses-
Income Before Tax (EBT)-209,248-160,854
EBIT - interestExpense = -58,976
-209,248
-150,272
Interest Expense58,976
Earnings Before Interest and Taxes (EBIT)--150,272
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax-209,248
Tax Provision--
Net Income From Continuing Ops-209,248-209,248
Net Income-209,248
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net5,29158,976
 

Technical Analysis of Esperion
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Esperion. The general trend of Esperion is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Esperion's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Esperion Therapeutics Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.804 < 2.988 < 3.948.

The bearish price targets are: 1.53 > 1.292 > 1.282.

Tweet this
Esperion Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Esperion Therapeutics Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Esperion Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Esperion Therapeutics Inc.

Esperion Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartEsperion Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Esperion Therapeutics Inc. The current adx is .

Esperion Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Esperion Therapeutics Inc.

Esperion Therapeutics Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Esperion Therapeutics Inc.

Esperion Therapeutics Inc Daily Relative Strength Index (RSI) ChartEsperion Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Esperion Therapeutics Inc.

Esperion Therapeutics Inc Daily Stochastic Oscillator ChartEsperion Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Esperion Therapeutics Inc.

Esperion Therapeutics Inc Daily Commodity Channel Index (CCI) ChartEsperion Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Esperion Therapeutics Inc.

Esperion Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartEsperion Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Esperion Therapeutics Inc.

Esperion Therapeutics Inc Daily Williams %R ChartEsperion Therapeutics Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Esperion Therapeutics Inc.

Esperion Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Esperion Therapeutics Inc.

Esperion Therapeutics Inc Daily Average True Range (ATR) ChartEsperion Therapeutics Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Esperion Therapeutics Inc.

Esperion Therapeutics Inc Daily On-Balance Volume (OBV) ChartEsperion Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Esperion Therapeutics Inc.

Esperion Therapeutics Inc Daily Money Flow Index (MFI) ChartEsperion Therapeutics Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Esperion Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-28 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-05 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-07 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-14 00:00:00SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-19 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-21 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-29 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-08 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-10 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-15 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-01-16 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-18 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-19 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-24 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-01 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-02-09 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-20 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-29 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-01 00:00:00DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-04 00:00:00DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-05 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-08 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-11 00:00:00ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-14 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-15 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-20 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21 00:00:00ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-22 00:00:00MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-25 00:00:00MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-27 00:00:00STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28 00:00:00STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02 00:00:00CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-03 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-04-05 00:00:00BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-08 00:00:00RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-10 00:00:00CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-11 00:00:00MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12 00:00:00SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16 00:00:00CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-17 00:00:00MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

Esperion Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Esperion Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.525
Total0/1 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Esperion with someone you think should read this too:
  • Are you bullish or bearish on Esperion? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Esperion? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Esperion Therapeutics Inc

I send you an email if I find something interesting about Esperion Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Esperion Therapeutics Inc.

Receive notifications about Esperion Therapeutics Inc in your mailbox!